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Glass polyalkenoate cements (GPCs) are acid base cements formed by the 
reaction of an aqueous solution of polyalkenoic acid, usually polyacrylic acid (PAA) 
with an acid degradable aluminosilicate glass. The result of the reaction is cement 
consisting of reacted and unreacted glass particles embedded in a polysalt matrix. In 
addition to these conventional GPCs, aluminium free glass polyalkenoate cements 
based on zinc silicate glasses (Zn-GPCs) exhibit significant potential as bone cements 
for several reasons. Primarily, they are formulated without the inclusion of aluminium 
(Al) [1] in the glass phase and thus eliminate clinical complications arising from the 
release of the Al3+ ion from the cement in vivo. Such complications have, in the past, 
included aluminium induced encephalopathy [2-5] and defective mineralisation of 
cancellous bone [6]. Secondly, Zn-GPCs set without a significant evolution of heat, 
when compared with commercial bone cements such as Spineplex ® (Stryker, 
Limerick, Ireland). Finally, these materials can be tailored to release clinically 
beneficial ions into surrounding tissues [7]. In addition to Zn, these cements have 
been synthesized to contain strontium (Sr) [8, 9]. Both Sr and Zn inhibit osteoclastic 
turnover and promote osteoblastic turnover, resulting in increased bone strength and 
decreased fracture risk [10-14]. 
 
Conventional GPCs bond directly to hydroxyapatite (HA) the mineral phase of 
tooth and bone, via the adsorption of carboxylate groups of the polyacid chains into 
the HA structure [15]. This indicates all conventional GPCs are capable of bonding to 
living bone. However, it has been postulated that an essential requirement for a 
material to bond to living bone lay in its ability to form a bone like crystalline apatite 
layer at its surface in vivo and that such a system can be replicated using simulated 
body fluid (SBF) [16]. Kamitakahara et al. recently used SBF to evaluate the bone 
bonding ability of conventional GPCs and found that PAA inhibited the formation of 
an apatite layer at the surface of GPCs and thus concluded that they were unlikely to 
bond to bone in vivo [17].  
  
Given these conflicting viewpoints, the authors have previously evaluated the 
ability of Zn-GPCs to form a bone like apatite layer in vitro using SBF [1, 9]. It was 
shown that calcium phosphate layers are produced on Zn-GPCs immersed in SBF 
within 24 hours. However, thin film x-ray diffraction (TF-XRD) indicates no 
crystallinity within the surface layer, and chemical analysis using scanning electron 
microscopy (SEM) and energy dispersive x-ray spectroscopy (EDS) of the surface 
layers is complicated by the collection of elemental signatures from the cement 
sample itself.  
 
In order to eliminate these issues, this letter seeks to validate the amorphous 
nature and composition of the surface layers observed on Zn-GPCs after immersion in 
SBF using transmission electron microscopy. 
 
One glass composition 0.08SrO / 0.08CaO / 0.36ZnO / 0.48 SiO2 (mol. 
fraction), was synthesized.  Appropriate amounts of analytical grade strontium 
carbonate, calcium carbonate, zinc oxide and silicon dioxide (Sigma Aldrich, Dublin, 
Ireland), were weighed out in a plastic tub and mixed in a ball mill for one hour, then 
dried (100°C, 1Hr).  The pre-fired glass batch was then transferred to a platinum 
crucible for firing (1480°C, 1Hr). The glass melt was subsequently quenched into 
water and the resulting frit was dried, ground and sieved to retrieve a <45µm glass 
powder. The glass was then annealed (645°C, 3h) for subsequent use in Zn-GPC 
specimen preparation. 
  
One Zn-GPC (termed BT102) was prepared by mixing the glass with a 50wt% 
aqueous solution of PAA; Mw = 80,800 (Advanced Healthcare, UK) on a clean glass 
slab with a dental spatula at a powder liquid ratio of 2:1.5.  
 
SBF was produced in accordance with the literature [16]. The composition is 
illustrated in Table 2. Reagents were dissolved in sequential order (as per Table 2) 
into 500ml of purified water (Reagecon, Shannon, Ireland) using a magnetic stirrer. 
The solution was maintained at 36.5°C (±1.5°C) using a water bath. 1M-HCL was 
titrated to adjust the pH of the SBF to 7.40.  Purified water was then added to adjust 
the total volume of liquid to one litre. Once prepared, the SBF was stored for 24 hours 
(5°C) to ensure that no precipitation occurred.  
 
INSERT TABLE 1 HERE 
 
BT102 (n=3, per incubation period) was prepared as described previously. 
Each specimen of cement was subsequently immersed in a volume of SBF such that 
the following equation was satisfied: 
 
Vs = Sa/10 …Equation 2  
 Where: 
Vs is the volume of SBF (ml). 
Sa is the surface area of the specimen (mm2). 
 
Specimens were stored in plastic containers for 30 and 90 days. After the 
specified incubation times, the cements were removed from the SBF, gently rinsed in 
deionised water, placed on individually labelled sheets of filter paper and oven dried 
(37 °C, 24 h).  
 
TEM specimens were prepared by wiping a Formbar-backed carbon-coated 
copper grid (Agar Scientific, Stanstead, England) over the sample surface. Particles of 
the apatite layer attached to the grid. Transmission electron microscopy was 
conducted using a JEOL JEM-2011 electron microscope operated at an accelerating 
voltage of 200 kV. Images were recorded using a Gatan DualVision 600t CCD 
camera attached to the microscope and were analysed using Gatan Digital Micrograph 
Version 3.11.1. The TEM was calibrated for diffraction and imaging mode using 
standard samples.  Energy dispersive x-ray analysis was undertaken with a Princeton 
Gamma Tech Prism 1G system with a 10mm2 silicon detector attached to the TEM 
and the peaks were analysed with Imix 10.594 software. The resolution of the system 
was calibrated with manganese (Mn). 
 
The rationale for the prolonged periods of immersion of BT102 in SBF was 
twofold. In the first instance, prolonged immersion ensured the development of a 
thick dense surface layer, such that TEM samples could be readily obtained. 
Secondly, it was contended that increased immersion time over conventional 
procedures may facilitate crystallisation of the surface layer. 
 
TEM analysis indicated a porous type structure, typified by the image shown 
in Figure 1a and 2. Selected area diffraction analysis indicated an amorphous structure 
as indicated in Figure 1b. The results indicated in Figure 1 and 2 were found to be 
representative of the sample as a whole, after a number of different areas were 
analysed and varying selected area diffraction apertures used to record the diffraction 
pattern. 
The compositional elements of the surface layer, as identified by EDS (Figure 
3) indicate the presence of calcium (Ca), phosphorus (P), zinc (Zn) and strontium (Sr) 
within the amorphous structure, with the presence of copper (Cu) owing to the Cu-
grid on which the sample is placed for analysis. Critically, this composition, in 
particular the inclusion of Zn in the structure, explicates the lack of crystallinity 
associated with the formation of the apatite layers observed on  Zn-GPCs after 
immersion in SBF [1, 9]. Zn-GPCs release clinically beneficial amounts of Zn2+ from 
the mantle of set cements for prolonged periods of time to inhibit bacterial 
colonization of the implant [7]. However, literature shows that Zn is effective at 
inhibiting the crystallisation of HA [18]; one report states that Zn is 1000 times more 
effective at inhibiting the crystallization kinetics of hydroxyapatite than magnesium 
(Mg) [19]. As such the release of Zn2+ and its subsequent inclusion in the apatite layer 
favours the formation of amorphous apatite (Figures 1 and 2), as opposed to the 
deposition of crystalline apatite on conventional GPCs examined under simulated in 
vivo conditions [20]. However, the presence of such an amorphous layer is 
comparable to the biological formation of HA in vivo, where prior to the formation of 
crystalline apatite, the predominant precursor has been cited as amorphous calcium 
phosphate (ACP) [21]. The ability of Zn-GPCs to produce amorphous apatite layer in 
vivo is related to zinc release and its subsequent uptake by the precipitating apatite 
layer. The apatite layer observed in this work is similar to that contended to occur in 
the natural mineralisation process in bone [21] and indicates that these materials will 
likely bond directly to living bone tissue [16]. 
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Tables & Figures. 
 
Table 1: Order and amounts of reagents used to prepare 1000ml of SBF. 
Order Reagent Quantity 
1 NaCl 8.035g 
2 NaHCO3 0.355g 
3 KCl 0.225g 
4 K2HPO4.3H2O 0.231g 
5 MgCl2.6H2O 0.311g 
6 1.0M-HCl 39ml 
7 CaCl2 0.292g 
8 Na2SO4 0.072g 
9 Tris 6.118g 
10 1.0M-HCl 0-5ml 
 
   
 (a)      (b) 
Figure 1: (a) TEM micrograph of surface layer (X20k) after 30 days immersion in SBF. (b) Diffuse 
selected area diffraction pattern indicating amorphous structure obtained from (a) indicating amorphous 
structure. 
 
 Figure 2: TEM micrograph of surface layer after 90 days immersion in SBF. 
 
 
 
Figure 3: EDS results for surface layer observed on cements after 30days incubation in SBF.  
 
 
